Tag: specialty generics market share

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Specialty Generics Market From 2025 to 2029?

The size of the specialty generics market has seen a swift expansion in the last few years. From $95.87 billion in 2024, it is predicted to advance to $107.14 billion in 2025 with a compound annual growth rate (CAGR) of 11.7%. Factors that contributed to growth during the historic period include the expiration of patents for brand-name drugs, an escalating demand for affordable substitutes, regulatory encouragement for the approval of generic drugs, rising pressures of healthcare costs, an increase in chronic illnesses, and a growing aging populace.

The market size for specialty generics is projected to experience a significant increase in the coming years, growing to “$185.68 billion in 2029 with a 14.7% compound annual growth rate (CAGR). Several factors such as the growth of the biosimilars market, emphasis on the development of complex generic drugs, increasing concentration on specialty generic injectables, the use of 3D printing in specialty generic manufacturing, and the expansion of specialty generics in emerging markets all contribute to the growth projected for this period. Noteworthy trends forecasted for this period include the increased personalization and targeting of specialty generics, strategic alliances, and collaborations in generic drug development, focus on creating abuse-deterrent formulations, incorporation of digital health technologies in specialty generics and regulatory measures aimed at fast-tracking the approval of complex generics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Elements Are Contributing To Growth In The Specialty Generics Market?

The rise in chronic illnesses is anticipated to boost the demand in the specialty generic market. These persistent diseases, often incurable, can sometimes be managed or even cured. The shift in lifestyle, dietary habits, and lack of weight management are often to blame for chronic health conditions, and some prolonged chronic infections can lead to a higher risk of cancer. As people become more susceptible to these illnesses, there is an increased need for specialty generic treatments to manage complex chronic diseases. For example, the World Health Organization, a UN-specialized agency based in Switzerland, reported in September 2022 that every year, globally, there were 41 million deaths, accounting for 74% of all deaths caused by non-communicable diseases or chronic diseases. The breakdown included 17.9 million deaths from heart-related diseases, 9.3 million deaths from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rise in chronic illnesses is fueling growth in the specialty generic market.

Which Segments Are Detailed In The Global Specialty Generics Market Report?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

What Notable Trends Are Shaping The Direction Of The Specialty Generics Market?

Prominent players in the specialty generic market, like Lisdexamfetamine Dimesylate, are getting approved to fulfill the urgent demand for medication. Specialty generics approvals denote the official license given to pharmaceutical products that are bioequivalent and therapeutically the same as original brand specialty drugs, mainly used for treating complex or rare disorders, after their patent protection has lapsed. For example, Mallinckrodt plc, a specialty pharmaceutical firm located in Ireland, obtained FDA’s approval for its Lisdexamfetamine Dimesylate Capsules under its SpecGx LLC Specialty Generics division in August 2023. These are intended to handle Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic and a federally controlled substance (CII), used in treating ADHD, among other conditions.

Who Are The Key Contributors To Growth In The Specialty Generics Market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Region Is Projected To Lead The Specialty Generics Market By 2025?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Specialty Generics Market From 2025 to 2029?

The size of the specialty generics market has seen a swift expansion in the last few years. From $95.87 billion in 2024, it is predicted to advance to $107.14 billion in 2025 with a compound annual growth rate (CAGR) of 11.7%. Factors that contributed to growth during the historic period include the expiration of patents for brand-name drugs, an escalating demand for affordable substitutes, regulatory encouragement for the approval of generic drugs, rising pressures of healthcare costs, an increase in chronic illnesses, and a growing aging populace.

The market size for specialty generics is projected to experience a significant increase in the coming years, growing to “$185.68 billion in 2029 with a 14.7% compound annual growth rate (CAGR). Several factors such as the growth of the biosimilars market, emphasis on the development of complex generic drugs, increasing concentration on specialty generic injectables, the use of 3D printing in specialty generic manufacturing, and the expansion of specialty generics in emerging markets all contribute to the growth projected for this period. Noteworthy trends forecasted for this period include the increased personalization and targeting of specialty generics, strategic alliances, and collaborations in generic drug development, focus on creating abuse-deterrent formulations, incorporation of digital health technologies in specialty generics and regulatory measures aimed at fast-tracking the approval of complex generics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Elements Are Contributing To Growth In The Specialty Generics Market?

The rise in chronic illnesses is anticipated to boost the demand in the specialty generic market. These persistent diseases, often incurable, can sometimes be managed or even cured. The shift in lifestyle, dietary habits, and lack of weight management are often to blame for chronic health conditions, and some prolonged chronic infections can lead to a higher risk of cancer. As people become more susceptible to these illnesses, there is an increased need for specialty generic treatments to manage complex chronic diseases. For example, the World Health Organization, a UN-specialized agency based in Switzerland, reported in September 2022 that every year, globally, there were 41 million deaths, accounting for 74% of all deaths caused by non-communicable diseases or chronic diseases. The breakdown included 17.9 million deaths from heart-related diseases, 9.3 million deaths from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rise in chronic illnesses is fueling growth in the specialty generic market.

Which Segments Are Detailed In The Global Specialty Generics Market Report?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

What Notable Trends Are Shaping The Direction Of The Specialty Generics Market?

Prominent players in the specialty generic market, like Lisdexamfetamine Dimesylate, are getting approved to fulfill the urgent demand for medication. Specialty generics approvals denote the official license given to pharmaceutical products that are bioequivalent and therapeutically the same as original brand specialty drugs, mainly used for treating complex or rare disorders, after their patent protection has lapsed. For example, Mallinckrodt plc, a specialty pharmaceutical firm located in Ireland, obtained FDA’s approval for its Lisdexamfetamine Dimesylate Capsules under its SpecGx LLC Specialty Generics division in August 2023. These are intended to handle Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic and a federally controlled substance (CII), used in treating ADHD, among other conditions.

Who Are The Key Contributors To Growth In The Specialty Generics Market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Region Is Projected To Lead The Specialty Generics Market By 2025?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Does the Forecast Indicate for the Specialty Generics Market From 2025 to 2029?

The size of the specialty generics market has seen a swift expansion in the last few years. From $95.87 billion in 2024, it is predicted to advance to $107.14 billion in 2025 with a compound annual growth rate (CAGR) of 11.7%. Factors that contributed to growth during the historic period include the expiration of patents for brand-name drugs, an escalating demand for affordable substitutes, regulatory encouragement for the approval of generic drugs, rising pressures of healthcare costs, an increase in chronic illnesses, and a growing aging populace.

The market size for specialty generics is projected to experience a significant increase in the coming years, growing to “$185.68 billion in 2029 with a 14.7% compound annual growth rate (CAGR). Several factors such as the growth of the biosimilars market, emphasis on the development of complex generic drugs, increasing concentration on specialty generic injectables, the use of 3D printing in specialty generic manufacturing, and the expansion of specialty generics in emerging markets all contribute to the growth projected for this period. Noteworthy trends forecasted for this period include the increased personalization and targeting of specialty generics, strategic alliances, and collaborations in generic drug development, focus on creating abuse-deterrent formulations, incorporation of digital health technologies in specialty generics and regulatory measures aimed at fast-tracking the approval of complex generics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Elements Are Contributing To Growth In The Specialty Generics Market?

The rise in chronic illnesses is anticipated to boost the demand in the specialty generic market. These persistent diseases, often incurable, can sometimes be managed or even cured. The shift in lifestyle, dietary habits, and lack of weight management are often to blame for chronic health conditions, and some prolonged chronic infections can lead to a higher risk of cancer. As people become more susceptible to these illnesses, there is an increased need for specialty generic treatments to manage complex chronic diseases. For example, the World Health Organization, a UN-specialized agency based in Switzerland, reported in September 2022 that every year, globally, there were 41 million deaths, accounting for 74% of all deaths caused by non-communicable diseases or chronic diseases. The breakdown included 17.9 million deaths from heart-related diseases, 9.3 million deaths from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rise in chronic illnesses is fueling growth in the specialty generic market.

Which Segments Are Detailed In The Global Specialty Generics Market Report?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

What Notable Trends Are Shaping The Direction Of The Specialty Generics Market?

Prominent players in the specialty generic market, like Lisdexamfetamine Dimesylate, are getting approved to fulfill the urgent demand for medication. Specialty generics approvals denote the official license given to pharmaceutical products that are bioequivalent and therapeutically the same as original brand specialty drugs, mainly used for treating complex or rare disorders, after their patent protection has lapsed. For example, Mallinckrodt plc, a specialty pharmaceutical firm located in Ireland, obtained FDA’s approval for its Lisdexamfetamine Dimesylate Capsules under its SpecGx LLC Specialty Generics division in August 2023. These are intended to handle Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic and a federally controlled substance (CII), used in treating ADHD, among other conditions.

Who Are The Key Contributors To Growth In The Specialty Generics Market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Region Is Projected To Lead The Specialty Generics Market By 2025?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#What Does the Forecast Indicate for the Specialty Generics Market From 2025 to 2029?#_x000D_

The size of the specialty generics market has seen a fast-paced expansion in recent durations. The market, expected to rise from $95.87 billion in 2024, will further leap to $107.14 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 11.7%. Factors that have led to the growth in prior periods are the expiration of patents for proprietary drugs, a mounting demand for affordable options, supportive regulations for the approval of generic drugs, a significant increase in medical care costs, prevalence of chronic illnesses, and an aging demographic._x000D_

_x000D_

The market size of specialty generics is predicted to experience swift expansion in the following years, reaching an estimated value of $185.68 billion by 2029 with a compound annual growth rate (CAGR) of 14.7%. Factors contributing to this increase over the projected timeframe include the growth of the biosimilars market, the accentuation of complex generic drug development, heightened attention toward specialty generic injectables, the application of 3D printing in specialty generic creation, and the prospective market expansion in emerging countries. The future trends within this period are expected to encompass personalized and pinpointed specialty generics, strategic alliances, and partnerships in generic drug development. Additionally, emphasis on formulating abuse-deterrent medicines, incorporation of digital health technologies in specialty generics, and regulatory actions for quick approvals of complex generics are also projected._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp_x000D_

_x000D_

#What Elements Are Contributing To Growth In The Specialty Generics Market?#_x000D_

The increasing prevalence of chronic diseases are anticipated to fuel the demand for the specialty generic market. Chronic illnesses are persistent conditions that are typically incurable, albeit occasionally treatable and manageable. Factors such as lifestyle changes, dietary habits, and lack of weight control contribute to these chronic conditions, and certain chronic infections can also increase the risk of cancer. This rise in chronic disease incidence heightens the need for specialty generics to treat complex chronic conditions. For instance, in September 2022, data from the World Health Organization, a Switzerland-based arm of the United Nations, indicated that there were 41 million, or 74%, of global deaths each year resulting from non-communicable diseases (NCDs) or chronic diseases. These included 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. Consequently, the rise in chronic diseases is fuelling the growth of the specialty generic market._x000D_

_x000D_

#Which Segments Are Detailed In The Global Specialty Generics Market Report?#_x000D_

The specialty generics market covered in this report is segmented – _x000D_

_x000D_

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration_x000D_

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication_x000D_

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx_x000D_

_x000D_

Subsegments:_x000D_

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables _x000D_

2) By Oral: Tablets, Capsules, Liquid Formulations _x000D_

3) By Other Route Of Administration: Topical, Transdermal, Inhalation _x000D_

_x000D_

#Which Emerging Trends And Strategic Shifts Are Shaping The Specialty Generics Market?#_x000D_

Leading firms in the specialty generic market are gaining approvals for substances like Lisdexamfetamine Dimesylate to fulfill the urgent medication need. Obtaining approval for specialty generics is indicative of an official sanction granted to pharmaceutical products, which are bioequivalent and offer the same therapeutic results as branded specialty drugs. These drugs are commonly used for treating intricate or rare health conditions following the expiry of patent protection. To illustrate, Mallinckrodt plc, a specialty pharmaceutical organization based in Ireland, procured FDA approval in August 2023 for its Lisdexamfetamine Dimesylate Capsules. This product, under the SpecGx LLC Specialty Generics division, is meant for treating Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate, a specific type of specialty generic, is a federally controlled substance (CII) utilized in the treatment of ADHD and other related conditions._x000D_

_x000D_

#Who Are The Key Contributors To Growth In The Specialty Generics Market?#_x000D_

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report_x000D_

_x000D_

#Which Region Is Projected To Lead The Specialty Generics Market By 2025?#_x000D_

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Specialty Generics Market?

Recent years have witnessed a swift expansion in the size of the specialty generics market. The market, projected to surge from $95.87 billion in 2024 to $108.11 billion in 2025, is expected to have a compound annual growth rate (CAGR) of 12.8%. There are several contributing factors to the growth noted in the historical phase, including the expiration of patents for branded drugs, the escalating need for budget-friendly substitutes, regulations in place that support the approval of generic drugs, mounting pressure from rising healthcare costs, an increase in chronic illness cases, and the growth in the aging demographic.

What Growth Rate Is Forecasted for the Specialty Generics Market by 2029?

The market size for specialty generics is projected to experience a swift expansion in the upcoming years, reaching $189.72 billion in 2029 with a compound annual growth rate (CAGR) of 15.1%. The projected growth during the forecast period is due to factors such as the broadening of the biosimilars market, the focus on the development of complex generic drugs, the increased attention towards specialty generic injectables, the use of 3d printing in specialty generic production, and the burgeoning of specialty generics in emergent markets. Notable trends for the forecast duration include the customisation and targeting of specialty generics, the formation of strategic alliances and collaborations in generic drug advancement, the determination to create abuse-resistant formulations, the application of digital health technologies in specialty generics, and regulatory actions advocating for speedy approval of complex generics.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

Which Key Companies Are Shaping the Future of the Specialty Generics Market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Which Factors Are Driving Demand in the Specialty Generics Industry?

The swell in long-term illnesses is anticipated to boost specialty generic market demand. Chronic diseases are enduring health conditions that can be challenging to cure, if not impossible. However, they can occasionally be treated and managed. The rise in these conditions is often due to changing lifestyles, dietary habits, and failure to maintain a healthy body weight. Moreover, some persistent chronic infections may even increase the risk of cancer. Rising instances of these diseases necessitate the use of specialty generic medicines to treat complex chronic conditions. For example, in September 2022, the World Health Organization, a Switzerland-based special agency under the auspices of the United Nations, reported that there are 41 million yearly global deaths due to non-communicable or chronic diseases, which represents 74% of all global deaths. These include 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. As a result, the rise in chronic diseases is leading to an increase in the growth of the specialty generic market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

How Is the Specialty Generics Market Segmented by Several Divisions?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

What are the Emerging Market Trends Driving the Growth of the Specialty Generics Industry?

Leading corporations in the specialty generic market, like Mallinckrodt plc, are obtaining necessary approvals like the one for Lisdexamfetamine Dimesylate to respond to urgent need for medications. Approvals in this sector refers to regulatory permissions granted for pharmaceutical goods which are biologically and therapeutically comparable to brand-name specialty drugs, normally employed for complex or rare medical conditions, post the expiration of their patent protection. For instance, in August 2023, Mallinckrodt plc, a specialty pharmaceutical corporation based in Ireland, got the FDA’s consent for their Lisdexamfetamine Dimesylate Capsules, under their SpecGx LLC Specialty Generics division, for the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic and a federally regulated substance (CII) used for ADHD and other conditions.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Regions Are Driving Growth in the Specialty Generics Market?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

This Report Delivers Insight On:

1. How big is the specialty generics market, and how is it changing globally?

2. Who are the major companies in the specialty generics market, and how are they performing?

3. What are the key opportunities and risks in the specialty generics market right now?

4. Which products or customer segments are growing the most in the specialty generics market?

5. What factors are helping or slowing down the growth of the specialty generics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the specialty generics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Specialty Generics Market Through 2034?

The market size of specialty generics has experienced swift expansion in the preceding years. The figures are set to rise from $95.87 billion in 2024 to $108.11 billion in 2025, with a compound annual growth rate (CAGR) of 12.8%. Factors such as the patent expiration of branded medicines, a growing consumer preference for cost-effective substitutes, regulatory backing for approving generic medications, increasing financial strains in healthcare, rise in chronic ailments, and an aging populace have all contributed to the acceleration in the historical phase.

In the coming years, the specialty generics market is anticipated to expand rapidly, growing to a whopping $189.72 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. Various factors such as the development of the biosimilars market, the accentuation on the production of complex generic drugs, the increasing importance of specialty generic injectables, the implementation of 3D printing in specialty generic production, and the expansion of specialty generics in emerging markets are expected to drive this growth during the forecast period. Other significant trends predicted within this duration include the personalization and targeting of specialty generics, strategic alliances and collaborations for generic drug development, concentration on creating abuse-deterrent formulations, the incorporation of digital health technologies into specialty generics, and regulatory strategies to expedite the approval of intricate generics.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

What Are the Core Market Drivers Propelling Growth in the Specialty Generics Industry?

The specialty generic market is projected to be fueled by the rising prevalence of chronic illnesses. Chronic diseases are persistent ailments that can often be incurable. Yet they can sometimes be curable and manageable. Factors like the shift in lifestyle, dietary habits, and failure to maintain a healthy body weight contribute to the onset of chronic conditions, with some severe chronic infections also posing a risk of cancer. The increase in these diseases results in a higher need for specialty generic treatments for patients dealing with complex chronic illnesses. For example, the World Health Organization, a specialized agency of the United Nations based in Switzerland, stated in September 2022 that 41 million deaths occur annually worldwide due to non-communicable diseases or chronic diseases, making up 74% of total deaths. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the rising incidence of chronic diseases fuels the expansion of the specialty generic market.

How Is the Specialty Generics Market Segmented?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

Which Regions Are Driving the Next Phase of the Specialty Generics Market Growth?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Market Trends and Innovations Are Shaping the Future of the Specialty Generics Industry?

Leading corporations in the specialty generic market are gaining approvals like Lisdexamfetamine Dimesylate to meet the pressing demand for medication. Such approvals in the specialty generic sector indicate regulatory clearance given to pharma products that are bioequivalent and therapeutically identical to branded specialty drugs, commonly utilized for treating intricate or rare health conditions, post their patent protections’ expiration. For example, Mallinckrodt plc, a specialty pharmaceutical enterprise based in Ireland, achieved FDA consent for its SpecGx LLC Specialty Generics segment’s Lisdexamfetamine Dimesylate Capsules in August 2023, intended to cure Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a specialty generic variety and a federally regulated substance (CII) employed for treating ADHD along with other conditions.

View the full report here:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

How Is the Specialty Generics Market Defined and What Are Its Core Parameters?

The specialty generics refer to generic versions of drugs used to describe expensive, intricate, or high-touch generic versions of medications. It requires substantial service participation to manage. This specialty generic includes biologics and biosimilars, which have separate regulatory routes. The majority of specialty medications are used to treat various malignancies, rheumatoid arthritis, and multiple sclerosis.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theSpecialty Generics Market?

The surge in chronic diseases is driving the demand for the specialty generic market. Chronic diseases, including cardiovascular diseases, cancer, and diabetes, are responsible for a significant portion of global deaths. According to the World Health Organization, 74% of global deaths were caused by non-communicable diseases in 2022. As chronic diseases rise, the need for specialty generics to treat these conditions is increasing, thereby fueling the market’s growth.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

#What Long-Term Growth Rate is Expected for theSpecialty Generics Market Between 2025 and 2034?

The specialty generics market has experienced rapid growth in recent years. It will increase from $95.87 billion in 2024 to $108.11 billion in 2025, at a CAGR of 12.8%. The historical growth is attributed to the expiration of patents for brand-name drugs, the increasing demand for cost-effective alternatives, regulatory support for generic drug approvals, rising healthcare costs, and the growing prevalence of chronic diseases and an aging population.

The specialty generics market is expected to grow rapidly, reaching $189.72 billion by 2029 at a CAGR of 15.1%. This growth will be driven by the expansion of the biosimilars market, the focus on complex generic drug development, and the adoption of 3D printing. Major trends will include personalized generics, digital health technologies, and strategic partnerships.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

What Key Market Trends and Innovations Are Shaping the Future of theSpecialty Generics Industry?

In the specialty generic market, major companies are receiving approval for drugs like Lisdexamfetamine Dimesylate to address critical medical needs. In August 2023, Mallinckrodt plc, an Ireland-based specialty pharmaceutical company, received FDA approval for Lisdexamfetamine Dimesylate Capsules in the SpecGx LLC Specialty Generics segment to treat Attention-Deficit/Hyperactivity Disorder (ADHD). This specialty generic drug is a controlled substance (CII) used for ADHD treatment.

Which Companies Are Leading the Charge in Expanding theSpecialty Generics Market Growth?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

How is the Global Specialty Generics Market Segemented?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=7781&type=smp

Which Geographics are Influencing the Growth of the Specialty Generics Market?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Gobal Specialty Generics Maret 2025, By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the specialty generics market?

Over recent years, the specialty generics market has seen swift expansion. It is projected to accelerate from a market size of $95.87 billion in 2024, reaching $108.11 billion in 2025, with a compound annual growth rate (CAGR) of 12.8%. Factors contributing to this growth during the historic period include the expiration of brand-name drug patents, boosted demand for affordable alternatives, regulatory encouragement for generic drug authorization, mounting pressure due to climbing healthcare costs, as well as the increase in chronic diseases coupled with an aging population.

What will be the specialty generics market size in the future?

Anticipated to experience swift expansion in the succeeding years, the market size for specialty generics is predicted to reach a sum of $189.72 billion by 2029, showcasing a compound annual growth rate (CAGR) of 15.1%. Various factors contributing to this projected inclination during the forecast period encompass the growing biosimilars market, increased concentration on the development of complex generic drugs, the rising attention towards specialty generic injectables, the incorporation of 3D printing in specialty generic production, and the surge of specialty generics in developing markets. The forecast period also discloses significant trends including personal and targeted specialty generics, strategic alliances, and partnerships in the development of generic drugs, a focus on creating abuse-deterring formulations, the inclusion of digital health technology in specialty generics, and regulatory actions for sped-up approval of complex generics.

Get your specialty generics market report here!

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

What main drivers are fueling expansion in the specialty generics market?

The rise in long-term illnesses is anticipated to fuel demand in the specialty generic market. Chronic diseases are typically enduring and not always curable, yet sometimes controllable. Factors such as shifting lifestyles, dietary habits, and the lack of body weight management contribute to such enduring illnesses, and some can even increase the risk of cancer. As exposure to these diseases increases, the necessity for specialty generics also escalates, primarily to manage complex chronic diseases. For example, in September 2022, World Health Organization, a specialized UN agency based in Switzerland, reported 41 million deaths globally, 74% of which were due to non-communicable or chronic diseases. Breakdown showed 17.9 million cardiovascular-related deaths, 9.3 million cancer-related deaths, 4.1 million chronic respiratory disease-related deaths, and 2.0 million diabetes-related deaths. Consequently, the sharp rise in chronic illnesses is a primary driver of growth for the specialty generic market.

What key areas define the segmentation of the global specialty generics market?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

Who are the dominant players expanding their reach in the specialty generics market?

Major companies operating in the specialty generics market include Teva Pharmaceutical Industries Ltd., Endo International plc, Akorn Operating Company LLC, Mallinckrodt Pharmaceuticals, Dr. Reddy’s Laboratories Ltd., Fresenius Kabi Brasil Ltda, STADA Arzneimittel AG, Cipla Limited, Lupin Ltd, Aurobindo Pharma Limited, Aspen Pharmacare Holdings Limited, Pfizer Inc., Accord Healthcare Limited, Amneal Pharmaceuticals Inc., Sandoz International GmbH, Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Perrigo Company plc, Impax Laboratories Inc., Par Pharmaceutical Companies Inc., Alvogen, Alkem Laboratories Ltd., Wockhardt Ltd., Strides Pharma Science Limited, Indoco Remedies Ltd., Unichem Laboratories Ltd., Alembic Pharmaceuticals Ltd., Jubilant Life Sciences Ltd.

How are evolving market trends shaping specialty generics Strategies?

Leading businesses in the specialty generic market, such as Lisdexamfetamine Dimesylate, are acquiring approvals to fulfill the vital necessity for medications. Such approvals indicate the formal clearance given by regulatory bodies for pharmaceutical products, equivalent both bioequivalently and therapeutically to brand-name specialty drugs often used for complicated or rare health conditions, once their patent cover has expired. For example, the Ireland-based specialized pharmaceutical firm, Mallinckrodt plc, in August 2023, secured FDA approval for their Lisdexamfetamine Dimesylate Capsules under the SpecGx LLC Specialty Generics segment, intended for treating Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate constitutes a kind of specialty generic and is a federally regulated substance (CII), used in ADHD and other medical treatments.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=7781

Which regions are emerging as leaders in the specialty generics market?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Specialty Generics Market Grow Over the Forecast Period Based on Its Expected CAGR?

Over the past few years, the specialty generics market has seen rapid expansion. This market is predicted to expand from $95.87 billion in 2024 to $108.11 billion in 2025, displaying a compound annual growth rate (CAGR) of 12.8%. The previous growth surge in this market can be attributed to various factors such as the expiry of patents for branded drugs, a rising demand for cost-effective alternatives, increased regulatory support for the approval of generic drugs, growing pressures on healthcare costs, an increase in chronic diseases, and an aging population.

In the coming years, we anticipate quick expansion in the specialty generics market, with its value expected to reach $189.72 billion in 2029, reflecting a compound annual growth rate (CAGR) of 15.1%. This forecasted growth can be linked to several factors including the broadening of the biosimilars market, an intensified focus on the development of complex generic drugs, a rising interest in specialty generic injectables, the use of 3D printing technology in specialty generic manufacturing, and an emerging market growth. The period also highlights major trends like personalization and targeting of specialty generics, strategic associations and collaborations in generic drug development, focus on creating abuse-resistant formulations, incorporation of digital health technologies in specialty generics, and regulatory efforts for faster approval of complex generics.

What Strategic Factors Are Influencing the Accelerated Growth of the specialty generics Market?

A rise in chronic illnesses is anticipated to drive the specialty generic market’s growth. These persistent ailments are often incurable but can sometimes be managed or even cured. Lifestyle changes, dietary habits, and failure to maintain a healthy weight contribute to these long-term diseases, with some even posing a risk of developing into cancer. The increasing prevalence of these conditions underlines the necessity of specialty generics in treating complex chronic diseases. For example, in September 2022, the World Health Organization, a specialized United Nations agency based in Switzerland, reported 41 million global deaths annually due to non-communicable or chronic diseases, constituting 74% of total deaths. The figures included 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Consequently, the escalating incidence of chronic diseases is fueling the growth of the specialty generic market.

Request Your Free Specialty Generics Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=7781&type=smp

Who Are the Dominant Players Expanding Their Reach in the Specialty Generics Market?

Major companies operating in the specialty generics market include:

• Teva Pharmaceutical Industries Ltd._x000D_

• Endo International plc_x000D_

• Akorn Operating Company LLC_x000D_

• Mallinckrodt Pharmaceuticals_x000D_

• Dr. Reddy’s Laboratories Ltd._x000D_

What Are the Top Trends Shaping the Evolution of the Specialty Generics Market?

Leading corporations in the specialty generic market, such as Lisdexamfetamine Dimesylate, are being authorized to meet the urgent demand for medication. Approval in specialty generics is the regulatory permission issued for drugs that are bioequivalent and therapeutically equal to proprietary specialty medicines typically used to treat intricate or rare health conditions once their patent protection has lapsed. For example, Mallinckrodt plc, a specialty pharmaceutical company based in Ireland, was granted FDA approval in August 2023 for its Lisdexamfetamine Dimesylate Capsules under the SpecGx LLC Specialty Generics division to treat Attention-Deficit/Hyperactivity Disorder (ADHD). Lisdexamfetamine Dimesylate is a kind of specialty generic and a federally regulated substance (CII) used for treating ADHD and other conditions.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/specialty-generics-global-market-report

Which Key Segments of the Specialty Generics Market Are Poised for Growth and Innovation?

The specialty generics market covered in this report is segmented –

1) By Route Of Administration: Injectables, Oral, Other Route Of Administration

2) By Indication: Oncology, Autoimmune Diseases, Infectious Diseases, Other Indication

3) By Distribution Channel: Retail Pharmacies, Specialty Pharmacies, Hospital Pharmaciesx

Subsegments:

1) By Injectables: Intravenous (IV) Injectables, Intramuscular (IM) Injectables, Subcutaneous (SC) Injectables

2) By Oral: Tablets, Capsules, Liquid Formulations

3) By Other Route Of Administration: Topical, Transdermal, Inhalation

Which Regions Are Setting the Pace for Specialty Generics Market Growth?

North America was the largest region in the specialty generics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the specialty generics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Specialty Generics Market?

The specialty generics refer to generic versions of drugs used to describe expensive, intricate, or high-touch generic versions of medications. It requires substantial service participation to manage. This specialty generic includes biologics and biosimilars, which have separate regulatory routes. The majority of specialty medications are used to treat various malignancies, rheumatoid arthritis, and multiple sclerosis.

Browse Through More Similar Reports By The Business Research Company:

Gastrointestinal Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/gastrointestinal-drug-global-market-report

Pharmacies and Drug Stores Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmacies-and-drug-stores-global-market-report

Nutritional Feed Additives Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: